These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 1315366)
21. Acyclovir Sensitivity and Neurovirulence of Herpes Simplex Virus Type 1 with Amino Acid Substitutions in the Viral Thymidine Kinase Gene, Which Were Detected in the Patients with Intractable Herpes Simplex Encephalitis Previously Reported. Inagaki T; Satoh M; Fujii H; Yamada S; Shibamura M; Yoshikawa T; Harada S; Takeyama H; Saijo M Jpn J Infect Dis; 2018 Sep; 71(5):343-349. PubMed ID: 29848849 [TBL] [Abstract][Full Text] [Related]
22. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus. Shimada Y; Suzuki M; Shirasaki F; Saito E; Sogo K; Hasegawa M; Takehara K; Phromjai J; Chuhjo T; Shiraki K J Med Virol; 2007 Nov; 79(11):1731-40. PubMed ID: 17854045 [TBL] [Abstract][Full Text] [Related]
23. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates. Shin YK; Cai GY; Weinberg A; Leary JJ; Levin MJ J Clin Microbiol; 2001 Mar; 39(3):913-7. PubMed ID: 11230403 [TBL] [Abstract][Full Text] [Related]
24. Phenotypic and genotypic acyclovir resistance surveillance of genital herpes simplex virus 2 in South Africa. Muller EE; Maseko DV; Kularatne RS Antiviral Res; 2022 Apr; 200():105277. PubMed ID: 35271913 [TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children. Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105 [TBL] [Abstract][Full Text] [Related]
27. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells. Saijo M; Suzutani T; Yoshida I Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651 [TBL] [Abstract][Full Text] [Related]
28. CRISPR/Cas9-mediated genome editing of the thymidine kinase gene in a clinical HSV-1 isolate identifies F289S as novel acyclovir-resistant mutation. Zheng S; Verjans GMGM; Evers A; van den Wittenboer E; Tjhie JHT; Snoeck R; Wiertz EJHJ; Andrei G; van Kampen JJA; Lebbink RJ Antiviral Res; 2024 Aug; 228():105950. PubMed ID: 38944159 [TBL] [Abstract][Full Text] [Related]
29. An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice. Sakuma S; Yamamoto M; Kumano Y; Mori R Arch Virol; 1988; 101(3-4):169-82. PubMed ID: 2845890 [TBL] [Abstract][Full Text] [Related]
30. Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues. Bestman-Smith J; Schmit I; Papadopoulou B; Boivin G J Virol; 2001 Apr; 75(7):3105-10. PubMed ID: 11238837 [TBL] [Abstract][Full Text] [Related]
31. A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates. Palù G; Gerna G; Bevilacqua F; Marcello A Virus Res; 1992 Sep; 25(1-2):133-44. PubMed ID: 1329374 [TBL] [Abstract][Full Text] [Related]
33. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2. Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911 [TBL] [Abstract][Full Text] [Related]
34. Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses. Frobert E; Cortay JC; Ooka T; Najioullah F; Thouvenot D; Lina B; Morfin F Antiviral Res; 2008 Jul; 79(1):28-36. PubMed ID: 18336925 [TBL] [Abstract][Full Text] [Related]
35. Analysis of antiviral drug properties of thymidine kinase of herpes B virus using recombinant herpes simplex virus 1. Nguyen PHA; Fukushi S; Yamada S; Harada S; Yoshikawa T; Kinoshita H; Kawahara M; Ogawa T; Ebihara H; Moi ML; Saijo M Microbiol Spectr; 2024 Jan; 12(1):e0309123. PubMed ID: 38095468 [TBL] [Abstract][Full Text] [Related]
36. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay. Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227 [TBL] [Abstract][Full Text] [Related]
37. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. Gaudreau A; Hill E; Balfour HH; Erice A; Boivin G J Infect Dis; 1998 Aug; 178(2):297-303. PubMed ID: 9697707 [TBL] [Abstract][Full Text] [Related]
38. Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir. Kit S; Sheppard M; Ichimura H; Nusinoff-Lehrman S; Ellis MN; Fyfe JA; Otsuka H Antimicrob Agents Chemother; 1987 Oct; 31(10):1483-90. PubMed ID: 2829709 [TBL] [Abstract][Full Text] [Related]
39. Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals. van Velzen M; van Loenen FB; Meesters RJ; de Graaf M; Remeijer L; Luider TM; Osterhaus AD; Verjans GM J Infect Dis; 2012 May; 205(10):1539-43. PubMed ID: 22457282 [TBL] [Abstract][Full Text] [Related]
40. Monitoring of bystander effect of herpes simplex virus thymidine kinase/acyclovir system using fluorescence resonance energy transfer technique. Xiong T; Li Y; Ni F; Zhang F J Biomed Nanotechnol; 2012 Feb; 8(1):74-9. PubMed ID: 22515095 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]